CClinicalTrials.gg
CompletedNCT02695875Updated Apr 2, 2025

Comparative Study About the Effect of Aquatic Therapy vs Land-based Therapy in Women With Fibromyalgia

An interventional study of Aquatic therapy and Land-based therapy in Fibromyalgia, sponsored by Universidade da Coruña. Completed at 1 site in Spain. Open to female participants aged 35 Years to 64 Years. Per ClinicalTrials.gov, last updated 2025-04-02.

Sponsored by Universidade da Coruña · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
35 Years to 64 Years
Sex
Female
01

Study summary

Fibromyalgia is a disease whose incidence rate is increasing and causing a severe disability to those who suffer it. Currently, other treatment resources are being implemented, such as aquatic therapy. This therapy seems to provide positive results in different dimensions of fibromyalgia.

The main objective of the study is to determine the effectiveness of a physical therapy program in warm water vs. land-based therapy in women with fibromyalgia for pain reduction and improvement balance at the end of treatment and a month and a half later (follow-up).

The type of study is a randomized controlled opened trial. The sample is composed of 34 women with age between 35 and 64 years and fibromyalgia diagnosis who will be divided into 2 groups: Aquatic Therapy Group (n=17) and Land-Based Therapy Group (n=17). This study will have two primary outcomes: Pain and balance. The intensity of pain will be assessed using the visual analog scale (VAS) and the pain threshold for each one of the 18 tender points will be assessed using a electronic algometer. Static balance will be evaluated with the Romberg's test and the dynamic balance with the Timed Up \& Go test (TUG) and Berg Balance Scale. Both type of balance will be recorded in slow motion and then, will be analysed with a motion software. Secondary outcomes are: The impact of fibromyalgia on patient's lives, that will be measured with the "Revised Fibromyalgia Impact Questionnaire" (FIQR); the sleep quality, that will be assessed with the "Pittsburgh Sleep Quality Index" (PSQI); the fatigue, that will be evaluated witn the "Multidimensional Fatigue Inventory" (MFI); the physical capacity, that will be measured with the "six minute walk test" (SMWT) and confidence in balance that will be assessed with the "Activities-specific Balance Confidence" scale (ABC).

Each intervention will last one hour and will be made 3 times a week for three months . It will consist of 4 sections: Warming, exercises for static and dynamic balance training, stretching and relaxation. Statistical analysis will be made using the Statistical Package for the Social Sciences software, version 21.0 for Windows. p ≤ 0.05 will be the significance level set for all analysis.

02

Conditions studied

  • Fibromyalgia

Keywords

  • Fibromyalgia
  • Pain
  • Postural balance
  • Physical therapy
  • Aquatic therapy
03

In context

Fibromyalgia

1,336 studies on the registry are indexed under Fibromyalgia; 266 are open to participants now.

This study's enrollment of 40 is below the median of 60 across 1,035 interventional studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

Universidade da Coruña is the lead sponsor of 33 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 64 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Female.
  • Age range between 35 and 64 years.
  • Diagnosis of fibromyalgia according to the criteria of the American College of Rheumatology (ACR) in 1990 and 2010.
  • Mark ≥ 4 on the Visual Analogue Scale (VAS).
  • Mark ≥ 5 on the Visual Analogue Scale for balance included in The Revised Fibromyalgia Impact Questionnaire (FIQR).

Exclusion criteria

Exclusion Criteria:

  • History of severe trauma.
  • Neurological diseases (stroke, Parkinson's disease, dementia).
  • Frequent migraines.
  • Inflammatory rheumatic diseases.
  • People who have been treated in the past six months by traumatic injuries.
  • Being pregnant.
  • Visual or hearing deficits uncorrected.
  • Infectious diseases.
  • Severe cardiovascular disease.
  • People who do exercise regularly more than 20 minutes, more than 3 times a week in the past 3 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Aquatic therapy

    Aquatic therapy is the experimental group. This therapy will take place in a warm pool which is located in Rialta's Sports Complex. Aquatic therapy session will be conducted by the main researcher with the help of an assistant. Because the number of patients (n=17), they will be subdivided into two subgroups of 8 and 9 people respectively in order to ensure the safety and care of patients. The intervention will last for one hour: Warming (15 minutes); exercises to train the static and dynamic balance (25 minutes); stretching (10 minutes); relaxation (10 minutes). Over 12 weeks of treatment, difficulty in performing exercises to train balance will increase progressively.

    Procedure: Aquatic therapy

  • Other
    Land-based therapy

    The description is the same as aquatic therapy. The difference is land-based therapy sessions will be made at Faculty of Physiotherapy at University of "A Coruña".

    Procedure: Land-based therapy

Interventions

  • ProcedureAquatic therapy

    Pool material is contributed by Maria José Jove Foundation. The exercises that will be made during treatment, are designed and developed to improve "core" muscles and, in this way, improve postural balance.

  • ProcedureLand-based therapy

    The material is contributed by Faculty of Physiotherapy at University of "A Coruña". The exercises that will be made during treatment, are designed and developed to improve "core" muscles and, in this way, improve postural balance.

06

What researchers measure

Primary outcomes

  1. Change from baseline Pain at 3 months of therapy and one month and a half after treatment.

    Pain will be assessed using the visual analog scale (VAS).

    Time frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

  2. Change from baseline Static Balance at 3 months of therapy and one month and a half after treatment.

    It will be evaluated with the Romberg's test, whose execution will be filmed in slow motion and then, these videos will be analysed with a motion software.

    Time frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

  3. Change from baseline Dynamic Balance at 3 months of therapy and one month and a half after treatment.

    It will be assessed using the Timed Up \& Go test (TUG), whose execution will be filmed in slow motion and then, these videos will be analysed with a motion software.

    Time frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

Secondary outcomes

  1. Change from baseline Quality of Life at 3 months of therapy and one month and a half after treatment.

    It will be measured with the "Revised Fibromyalgia Impact Questionnaire" (FIQR).

    Time frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

  2. Change from baseline Sleep Quality at 3 months of therapy and one month and a half after treatment.

    It will be assessed with the "Pittsburgh Sleep Quality Index" (PSQI).

    Time frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

  3. Change from baseline Fatigue at 3 months of therapy and one month and a half after treatment.

    It will be evaluated with the "Multidimensional Fatigue Inventory" (MFI).

    Time frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

  4. Change from baseline Physical Capacity at 3 months of therapy and one month and a half after treatment.

    It will be measured with the "six minute walk test" (SMWT).

    Time frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

  5. Change from baseline Confidence in Balance at 3 months of therapy and one month and a half after treatment.

    It will be assessed with the "Activities-specific Balance Confidence" scale (ABC).

    Time frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

  6. Change from baseline Pain Threshold for each one of the 18 tender points established at 3 months of therapy and one month and a half after treatment.

    It will be assessed using an electronic algometer.

    Time frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

  7. Change from baseline Functional Independence to perform activities of daily living at 3 months of therapy and one month and a half after treatment.

    It will be assessed using the Berg Balance Scale.

    Time frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

07

Study locations

1 site
  • Asociación Coruñesa de Fibromialgia, Síndrome de Fatiga Crónica y Sensibilidad Química Múltiple (ACOFIFA)
    A Coruña, 15006, Spain
08

References and documents

Publications

  • Rivas Neira S, Pasqual Marques A, Pegito Perez I, Fernandez Cervantes R, Vivas Costa J. Effectiveness of Aquatic Therapy vs Land-based Therapy for Balance and Pain in Women with Fibromyalgia: a study protocol for a randomised controlled trial. BMC Musculoskelet Disord. 2017 Jan 19;18(1):22. doi: 10.1186/s12891-016-1364-5. PubMed 28103853 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02695875
Lead sponsor
Universidade da Coruña
Responsible party
Sabela Rivas Neira, PhD (PhD, Universidade da Coruña) — Principal investigator
First posted
Mar 1, 2016
Start date
Feb 2016
Primary completion
Aug 2016
Completion
Dec 2024
Last update
Apr 2, 2025

Study contacts

Sabela Rivas Neira, Physiotherapy
principal investigator · Facultade de Fisioterapia da Universidade da Coruña
Jamile Vivas Costa, Physiotherapy
study director · Facultade de Fisioterapia da Universidade da Coruña

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion